Abstract:Editorial Office Annals of Translational Medicine Submitted Jul 21, 2024. Accepted for publication Aug 02, 2024. Published online Sep 05, 2024. doi: 10.21037/atm-2024-9 Erratum to: Ann Transl Med 2021;9:533 The article (1) titled "ESM1 promotes triple-negative breast cancer cell proliferation through activating AKT/NF-κB/Cyclin D1 pathway" (doi: 10.21037/atm-20-7005), unfortunately contains several errors that need to be corrected. The image in the upper right corner of Figure 2F, which represents the migration of the control shRNA-expressing MDA-MB-231 cells, was selected incorrectly. This image should be replaced with the correct one. In the legend of Figure 2, the order of the parts corresponding to Figure 2E-2I was incorrect. The correct order is: (E) colony formation assay on MDA-MB-231; (F) migration assay on MDA-MB-231; (G) migration assay on MDA-MB-468; (H) invasion assay on MDA-MB-231; (I) invasion assay on MDA-MB-468. The caption "MDA-MB-468" in Figure 4 was accidentally misplaced between Figure 4D and Figure 4F, which should be at the bottom of Figure 4C . In the legend of Figure 4, the order of the parts corresponding to Figure 4C-4F was incorrect. The correct order is: (C) CCK-8 assay on MDA-MB-468; (D) migration assay on MDA-MB-231; (E) migration assay on MDA-MB-468; (F) invasion assay on MDA-MB-231. Figure 2F in the original article: The legend of Figure 2 in the original article: Caption "MDA-MB-468" in Figure 4 in the original article: The legend of Figure 4 in the original article: The updated version of Figure 2 , containing the correct image for the "Control" in Figure 2F , and the updated version of Figure 4 with the correct position of the caption "MDA-MB-468", together with the correct legends for both figures, are shown below. These errors did not significantly affect either the results or the conclusions of the paper. Click here to view the updated version of the article. Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

Correction: Park et al. ABCA1-Mediated EMT Promotes Papillary Thyroid Cancer Malignancy through the ERK/Fra-1/ZEB1 Pathway. Cells 2023, 12, 274

Correction to: Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells

Erratum to ESM1 promotes triple-negative breast cancer cell proliferation through activating AKT/NF-κB/Cyclin D1 pathway

Correction: Antón-García et al. TGFβ1-Induced EMT in the MCF10A Mammary Epithelial Cell Line Model Is Executed Independently of SNAIL1 and ZEB1 but Relies on JUNB-Coordinated Transcriptional Regulation. Cancers 2023, 15, 588

Erratum: Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma

Correction To: EBV-miR-BART8-3p Induces Epithelial-Mesenchymal Transition and Promotes Metastasis of Nasopharyngeal Carcinoma Cells Through Activating NF-κB and Erk1/2 Pathways

Erratum: the PI 3-Kinase/akt Signaling Pathway is Activated Due to Aberrant Pten Expression and Targets Transcription Factors NF-κB and C-Myc in Pancreatic Cancer Cells

Correction: YY1 Complex Promotes Quaking Expression via Super-Enhancer Binding during EMT of Hepatocellular Carcinoma.

Erratum: Correction: Phosphorylation of proliferating cell nuclear antigen promotes cancer progression by activating the ATM/Akt/GSK3β/Snail signaling pathway (The Journal of biological chemistry (2019) 294 17 (7037-7045))

Correction to: Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling

Erratum: US-Guided Radiofrequency Ablation for Low-Risk Papillary Thyroid Microcarcinoma: Efficacy and Safety in a Large Population

Corrigendum: AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer

Erratum to erratum to miR-3614-3p suppresses cell aggressiveness of human breast cancer by targeting AKT3 and HDAC1 expression

Author Correction: An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation

N6 -methyladenosine-induced ERRγ triggers chemoresistance of cancer cells through upregulation of ABCB1 and metabolic reprogramming: Erratum

Erratum to "Bifunctional Tumor-Targeted Bioprobe for Phototheranosis"

FOXK2 promotes the proliferation of papillary thyroid cancer cell by down-regulating autophagy: Erratum

Correction for Lin Et Al., “Epstein-Barr Virus-Encoded Latent Membrane Protein 2A Promotes the Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma Via Metastatic Tumor Antigen 1 and Mechanistic Target of Rapamycin Signaling Induction”

Zinc-α2-glycoprotein 1 promotes EMT in colorectal cancer by filamin A mediated focal adhesion pathway: Erratum

Erratum: Adipocytes fuel gastric cancer omental metastasis via PITPNC1-mediated fatty acid metabolic reprogramming: Erratum

[Corrigendum] Inhibition of sphingosine-1-phosphate phosphatase 1 promotes cancer cells migration in gastric cancer: Clinical implications.